- Home
- CNFR vs CING Comparison
CNFR vs CING Comparison
Compare CNFR & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNFR
- CING
- Stock Information
- Founded
- CNFR 2009
- CING 2012
- Country
- CNFR United States
- CING United States
- Employees
- CNFR N/A
- CING N/A
- Industry
- CNFR Property-Casualty Insurers
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- CNFR Finance
- CING Health Care
- Exchange
- CNFR Nasdaq
- CING Nasdaq
- Market Cap
- CNFR 13.7M
- CING 14.4M
- IPO Year
- CNFR 2015
- CING 2021
- Fundamental
- Price
- CNFR $1.00
- CING $4.27
- Analyst Decision
- CNFR
- CING Strong Buy
- Analyst Count
- CNFR 0
- CING 3
- Target Price
- CNFR N/A
- CING $16.00
- AVG Volume (30 Days)
- CNFR 4.2K
- CING 118.1K
- Earning Date
- CNFR 04-03-2025
- CING 03-31-2025
- Dividend Yield
- CNFR N/A
- CING N/A
- EPS Growth
- CNFR N/A
- CING N/A
- EPS
- CNFR 2.40
- CING N/A
- Revenue
- CNFR $74,815,000.00
- CING N/A
- Revenue This Year
- CNFR N/A
- CING N/A
- Revenue Next Year
- CNFR $7.00
- CING N/A
- P/E Ratio
- CNFR $0.41
- CING N/A
- Revenue Growth
- CNFR N/A
- CING N/A
- 52 Week Low
- CNFR $0.65
- CING $1.80
- 52 Week High
- CNFR $1.91
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- CNFR 45.41
- CING 42.05
- Support Level
- CNFR $0.96
- CING $4.22
- Resistance Level
- CNFR $1.07
- CING $4.58
- Average True Range (ATR)
- CNFR 0.04
- CING 0.32
- MACD
- CNFR 0.01
- CING -0.04
- Stochastic Oscillator
- CNFR 47.78
- CING 12.64
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance company engaged in the sale of property and casualty insurance products. It is engaged in three classes of insurance businesses namely commercial lines, personal lines, and wholesale agency business. Within these three businesses, the company offers various insurance products and insurance agency services. The company views the commercial and personal lines segments as underwriting business. The wholesale agency business provides non-risk bearing revenue through commissions and policy fees. Its revenues are derived from premiums earned from insurance operations.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.